speb/financial-data huggingface dataset:
Financial scorecard for NAUT (Healthcare — Biotechnology, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 1.69
Market cap: 214763280 (USD: 214763280)
P/B ratio: 3.4142295287885607
Debt to equity: 0.1999
Current ratio: 11.85
Return on net tangible assets (%): -9.508015095384827
Buffett classification: The Gruesome
Analyst consensus upside (%): 3.092783505154642
Rule of 40 score: 0
Altman Z-score: 1.443305083842409 (Distress Zone)
Piotroski F-score: 2 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.5336107736853339
Total shareholder yield (%): 0.5336107736853339 (Low Return)
Momentum (%): 1m -28.389830508474574, 3m -35.49618320610687, 6m -18.35748792270531, 12m 122.36842105263158, composite 52.22421488688716 (Strong Uptrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 2, short score 11, recommendation: Strong Short (Melting Ice Cube)
Revenue deceleration: no
Accrual ratio: -0.005893339767031454
FCF conversion rate: 0.9260393277539634
Beneish M-score: -2.583354970950775 (Likely Safe)
ROE (%): -9.752876690511899
Asset turnover: 0
Equity multiplier (leverage): 1.22397374812534
ROE archetype: Low Return
Treasury beta 1y: 0.004128223065114296 (R-squared: 0.0003001685824127858)
Insider 90-day net shares: -4975000 (net value USD: -11684762.00)
ROIC (%): -63.16994472758596 (pretax: -79.96195535137464)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 36.91335740072203, ROIC 21.299638989169676, revenue growth 1y , 6m momentum 41.96750902527076
Sector percentiles: P/E , 6m momentum 48.45988538681949
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.08727934331671482
Base cash flow: -53813000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for NEOV (Industrials — Electrical Equipment & Parts, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 2.15
Market cap: 118048816 (USD: 118048816)
P/B ratio: 7.624059641148659
Debt to equity: 0.0654
Current ratio: 8.1
Interest coverage ratio: -50.67842115421733
Return on net tangible assets (%): -13.650232307052567
Buffett classification: The Gruesome
Analyst consensus upside (%): 159.74025974025975
Rule of 40 score: -286.6020592445482
Altman Z-score: 19.0468339811671 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 2.466400001843305
Total shareholder yield (%): 2.466400001843305 (Low Return)
Momentum (%): 1m 5.392156862745092, 3m -22.66187050359712, 6m -62.93103448275862, 12m -58.96946564885497, composite -48.88720242547736 (Strong Downtrend)
Lynch category: Speculative (confidence: Low)
Screener: long score 4, short score 7, recommendation: Neutral
Revenue growth 1y (%): 0.47728395490800324
Revenue deceleration: no
Accrual ratio: 0.10262021402836315
FCF conversion rate: 1.6061800910182995
Beneish M-score: -1.0531146277619512 (Strong Manipulation Signal)
ROE (%): -22.280795146639193
Net margin (%): -149.6454545544389
Asset turnover: 0.11312737704012624
Equity multiplier (leverage): 1.3161319685239465
ROE archetype: Low Return
Treasury beta 1y: 0.013604215999251311 (R-squared: 0.001973033065530138)
Insider 90-day net shares: 115000 (net value USD: 231757.00)
ROIC (%): -71.0732009369372 (pretax: -89.96607713536355)
Incremental ROIC 3y (%): 44.768470445541986 (pretax: 56.66894993106577)
Capital allocation category: Turnaround Compounder
Industry percentiles: P/E , P/B 62.096774193548384, ROIC 77.82258064516128, revenue growth 1y 39.11290322580645, 6m momentum 81.85483870967742
Sector percentiles: P/E , 6m momentum 85.20225294418843
Industry median P/E: 0.45393488063562387; industry median ROIC: 7.054948446910231
Sector median P/E: 0.48479532163742683; sector median ROIC: 7.0952301251284755
WACC: 0.05
Base cash flow: -4954026
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for NINE (Energy — Oil & Gas Equipment & Services, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 12.41
Market cap: 173119376 (USD: 173119376)
P/B ratio: 0.8537644178739093
Debt to equity: 0.9443
Current ratio: 2.13
Buffett classification: The Gruesome
Analyst consensus upside (%): 70.73170731707319
Rule of 40 score: 0
Piotroski F-score: 3 (Weak)
Magic formula: return on capital % 0.23662042330028613, earnings yield % 0.14424741849826678, rank 5704
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 147.94762199235282
Total shareholder yield (%): 147.94762199235282 (High Return)
Momentum (%): 1m 5.258693808312138, 3m 32.302771855010654, 6m , 12m , composite 32.302771855010654 ()
Lynch category: Cyclical (confidence: High)
Screener: long score 1, short score 2, recommendation: Neutral
Revenue deceleration: no
Beneish M-score: -2.6447794151058943 (Likely Safe)
Equity multiplier (leverage): 34.9768224102591
ROE archetype: Standard Business
Treasury beta 1y: 0.0034314158742171155 (R-squared: 0.0025012924649942727)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): 0.13185472869958756 (pretax: 0.16690471987289562)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 21.96969696969697, ROIC 70.45454545454545, revenue growth 1y , 6m momentum 
Industry median P/E: 14.518489818761033; industry median ROIC: 5.879956809181115
Sector median P/E: 11.598358576086895; sector median ROIC: 4.629877910100043
WACC: 0.11397996597403888
Base cash flow: -15316000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for NIVABUPA.NS (Financial Services — Insurance - Life, India)
Report date: 2026-03-31 (annual)
Stock price: 0.8943022295623452
Market cap: 160217595904 (USD: 1697939761.5938957)
P/E ratio: 1.0433353444150872
P/B ratio: 4.041072452370112
Debt to equity: 0.09880000000000001
Current ratio: 2.51
Return on net tangible assets (%): 3.752539360081259
Buffett classification: The Gruesome
Analyst consensus upside (%): 12565.232303090726
Rule of 40 score: 25.240848880460536
Piotroski F-score: 2 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m -1.4704407804791941, 3m 9.203039865203472, 6m 6.3406651152315865, 12m -10.735082446642064, composite 2.046933050809035 (Moderate Downtrend)
Lynch category: Slow Grower (confidence: Low)
Screener: long score 4, short score 3, recommendation: Neutral
Revenue growth 1y (%): 13.190775698744716
Net income growth 1y (%): -44.47557293154839
Revenue CAGR 3y (%): 30.239393980454942
Net income CAGR 3y (%): 108.57696342632752
FCF CAGR 3y (%): 10.329303010157865
Revenue deceleration: yes
Revenue growth consistency score: 21.92816701249552
Accrual ratio: -0.06582318044382619
FCF conversion rate: 6.5471020033644285
Beneish M-score: -2.3216405786176937 (Likely Safe)
ROE (%): 3.980553484008871
Net margin (%): 1.840520153118667
Asset turnover: 0.6447214707583588
Equity multiplier (leverage): 3.354522837815243
ROE archetype: Low Return
P/E z-score: 3.086526557324461
FCF z-score: 3.086526557324461
Treasury beta 1y: 0.04581351686720749 (R-squared: 0.003281176444593347)
Insider 90-day net shares: 0 (net value USD: 0.00)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 34.375, P/B 73.4375, ROIC , revenue growth 1y 28.125, 6m momentum 43.75
Sector percentiles: P/E 15.726849456802897, 6m momentum 26.539058458354887
Industry median P/E: 2.40435505821866; industry median ROIC: 2.783940447395565
Sector median P/E: 9.286368843069873; sector median ROIC: 1.3915857507207385
WACC: 0.10191226390508769
Base cash flow: 12528613.819415005
DCF price per share: base 0.002481541289128235, conservative 0.0016696030453630271, aggressive 0.003914272763012342
Financial scorecard for NOTV (Healthcare — Diagnostics & Research, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 0.01
Market cap: 2787563 (USD: 2787563)
Debt to equity: 6.326499999999999
Current ratio: 0.27
Interest coverage ratio: -1.2177344805518027
Buffett classification: The Gruesome
Rule of 40 score: -6.38990550818345
Altman Z-score: -1.9650438141759883 (Distress Zone)
Piotroski F-score: 4 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -423.2011976052201
Total shareholder yield (%): -423.2011976052201 (Minimal or Negative)
Lynch category: Turnaround (confidence: High)
Screener: long score 0, short score 10, recommendation: Strong Short (Melting Ice Cube)
Revenue growth 1y (%): -5.365861505916037
Revenue deceleration: no
Accrual ratio: -0.040778031590655045
FCF conversion rate: 0.09773000277204547
Beneish M-score: -2.7560878719192776 (Likely Safe)
ROE (%): -34.88768180181923
Net margin (%): -27.59579097677898
Asset turnover: 0.16377473109523272
Equity multiplier (leverage): 7.719379120259183
ROE archetype: Low Return
Treasury beta 1y: 4 (R-squared: 0.38399999999999984)
Insider 90-day net shares: -137114 (net value USD: -65231.00)
ROIC (%): -5.095832279998256 (pretax: -6.45042060759273)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B , ROIC 49.26470588235294, revenue growth 1y 48.529411764705884, 6m momentum 
Industry median P/E: 21.640734060420083; industry median ROIC: 2.9089897435686405
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.09734299611572696
Base cash flow: -16421000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for NOV.AX (Technology — Software - Infrastructure, Australia)
Report date: 2025-06-30 (annual)
Stock price: 0.006944444444444445
Market cap: 9347167 (USD: 6109259.4771241825)
Debt to equity: 1.4880000000000002
Current ratio: 0.86
Buffett classification: The Gruesome
Rule of 40 score: 0
Piotroski F-score: 1 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m 0.6944444444444402, 3m -67.5925925925926, 6m -66.20370370370371, 12m -65.0462962962963, composite -66.36121753937846 (Strong Downtrend)
Lynch category:  (confidence: Low)
Screener: long score 0, short score 3, recommendation: Neutral
Revenue deceleration: no
Revenue growth consistency score: 39.48236151429026
Beneish M-score: -2.48 (Likely Safe)
ROE archetype: Standard Business
Treasury beta 1y: 0.00525611252386059 (R-squared: 7.641672423097986e-05)
Insider 90-day net shares: 0 (net value USD: 0.00)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B , ROIC , revenue growth 1y , 6m momentum 89.36651583710407
Sector percentiles: P/E , 6m momentum 82.81614948281614
Industry median P/E: 5.36821412369575; industry median ROIC: 3.7232145830700096
Sector median P/E: 1.5433673469387754; sector median ROIC: 6.677876317240262
WACC: 0.12060000000000001
Base cash flow: 0
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for NOVAAGRI.NS (Basic Materials — Agricultural Inputs, India)
Report date: 2026-03-31 (annual)
Stock price: 0.23544591246903385
Market cap: 2053351936 (USD: 21760830.182280626)
P/E ratio: 0.1359054534830015
P/B ratio: 0.7097062130657
Debt to equity: 0.21660000000000001
Current ratio: 2.65
Interest coverage ratio: 4.6070479681997
Return on net tangible assets (%): -1.6696052445506564
Buffett classification: The Gruesome
Rule of 40 score: -27.00856594311297
Altman Z-score: 1.8966118660395916 (Grey Zone)
Piotroski F-score: 6 (Neutral)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 4.820464835290657
Total shareholder yield (%): 4.820464835290657 (Moderate Return)
Momentum (%): 1m -8.456936483649343, 3m -21.37042291532728, 6m -35.37941323241984, 12m -65.83384810660979, composite -39.80911495771618 (Strong Downtrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 4, short score 5, recommendation: Neutral
Revenue growth 1y (%): -19.375369182634337
Net income growth 1y (%): -57.557938275209295
Revenue CAGR 3y (%): 2.6295246052568277
Net income CAGR 3y (%): -18.308160252758952
FCF CAGR 3y (%): nan
Revenue deceleration: yes
Revenue growth consistency score: 16.69222997425166
Beneish M-score: 0.9058502609478427 (Strong Manipulation Signal)
ROE (%): 0.09479561334911397
Net margin (%): 0.3943527964173808
Asset turnover: 0.16198400450541406
Equity multiplier (leverage): 1.4839907190580455
ROE archetype: Low Return
P/E z-score: 3.3563036855376613
Treasury beta 1y: 0.033534110200009765 (R-squared: 0.0004829682977408363)
Insider 90-day net shares: 18571 (net value USD: 4674.00)
ROIC (%): 5.745093815960661 (pretax: 7.912553909194845)
Incremental ROIC 3y (%): -11.675899934197393 (pretax: -16.015115169439383)
Capital allocation category: Value Destroyer
Industry percentiles: P/E 18.421052631578945, P/B 21.052631578947366, ROIC 44.73684210526316, revenue growth 1y 53.50877192982456, 6m momentum 71.9298245614035
Sector percentiles: P/E 8.32870627429206, 6m momentum 59.93892282065519
Industry median P/E: 0.2566532600226159; industry median ROIC: 6.448334526806724
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.14734873709211027
Base cash flow: -409145.82450190745
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for NP (Financial Services — Insurance Brokers, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 30.24
Market cap: 4149185792 (USD: 4149185792)
P/E ratio: 65.14032592682997
Debt to equity: -1.063939481997394
Current ratio: 1.05
Interest coverage ratio: 3.8065703766638346
Return on net tangible assets (%): -3.2435114128515816
Buffett classification: The Great
Analyst consensus upside (%): 37.99090533278214
Rule of 40 score: 9.421559530053361
Altman Z-score: 0.9886590031802376 (Distress Zone)
Piotroski F-score: 8 (Strong)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.31331448268875206
Total shareholder yield (%): 0.31331448268875206 (Low Return)
Momentum (%): 1m 4.311831666091756, 3m 12.793733681462141, 6m 23.42857142857142, 12m , composite 18.11115255501678 (Moderate Uptrend)
Lynch category: Slow Grower (confidence: Medium)
Screener: long score 5, short score 7, recommendation: Neutral
Revenue growth 1y (%): 28.760263005484955
Net income growth 1y (%): -26.058959653888724
Revenue deceleration: no
Accrual ratio: -0.10951226800358578
FCF conversion rate: 2.1220574227786093
Beneish M-score: -2.753610552019722 (Likely Safe)
Net margin (%): 19.444370948538168
Asset turnover: 0.5019422955609416
ROE archetype: Standard Business
P/E z-score: 2.0306095649419125
FCF z-score: 2.03060956494191
Treasury beta 1y: -0.002692881228480882 (R-squared: 0.000367970402962184)
Insider 90-day net shares: -11244604 (net value USD: -297354986.00)
ROIC (%): 1246.3486141411968 (pretax: 1786.7561521252796)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 58.97435897435898, P/B , ROIC 0, revenue growth 1y 15.384615384615385, 6m momentum 2.564102564102564
Sector percentiles: P/E 56.80289705121573, 6m momentum 9.699948266942576
Industry median P/E: 20.70740316505789; industry median ROIC: 7.665445948403268
Sector median P/E: 9.286368843069873; sector median ROIC: 1.3915857507207385
WACC: 0.09795618428137016
Base cash flow: 37149000
DCF price per share: base 11.526622805136586, conservative 5.543948719431982, aggressive 22.155851589416997
Financial scorecard for NPCE (Healthcare — Medical Devices, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 14.81
Market cap: 504928352 (USD: 504928352)
P/B ratio: 31.017901394077764
Debt to equity: 4.8749
Current ratio: 5.38
Interest coverage ratio: -3.660749506903353
Return on net tangible assets (%): -43.53812093538121
Buffett classification: The Gruesome
Analyst consensus upside (%): 53.76425855513307
Rule of 40 score: -54.58851368470103
Altman Z-score: -3.4304722024132386 (Distress Zone)
Piotroski F-score: 4 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.07426796267522724
Total shareholder yield (%): 0.07426796267522724 (Low Return)
Momentum (%): 1m -8.692971639950668, 3m -11.845238095238097, 6m -11.370436864153204, 12m 63.285556780595364, composite 18.538545686083086 (Strong Uptrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 0, short score 12, recommendation: Strong Short (Melting Ice Cube)
Revenue growth 1y (%): -2.0245071923281843
Revenue deceleration: no
Accrual ratio: -0.0065733164435619156
FCF conversion rate: 0.899536552548961
Beneish M-score: -1.1586259323876198 (Strong Manipulation Signal)
ROE (%): -39.952217410780946
Net margin (%): -30.310857350009062
Asset turnover: 0.2158630167805422
Equity multiplier (leverage): 6.10610721218456
ROE archetype: Low Return
Treasury beta 1y: 0.001001074163250751 (R-squared: 5.090687613662368e-05)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): -44.800485942381115 (pretax: -56.70947587643179)
Incremental ROIC 3y (%): 1154.136200716846 (pretax: 1460.931899641577)
Capital allocation category: Turnaround Compounder
Industry percentiles: P/E , P/B 65.28189910979229, ROIC 48.6646884272997, revenue growth 1y 45.6973293768546, 6m momentum 36.49851632047478
Sector percentiles: P/E , 6m momentum 41.4756446991404
Industry median P/E: 21.626420273203117; industry median ROIC: -5.9391058628332924
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.1428219108844561
Base cash flow: -19849000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for NTRA (Healthcare — Diagnostics & Research, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 261.99
Market cap: 37520994304 (USD: 37520994304)
P/B ratio: 16.14506969274269
Debt to equity: 0.1353
Current ratio: 2.96
Interest coverage ratio: -104.83856502242152
Return on net tangible assets (%): -6.873287149065531
Buffett classification: The Gruesome
Analyst consensus upside (%): 41.43707185359268
Rule of 40 score: -6.383365784934215
Altman Z-score: 25.906839899549446 (Safe Zone)
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -0.06850564724309498
Total shareholder yield (%): -0.06850564724309498 (Minimal or Negative)
Momentum (%): 1m 0.7770127322383281, 3m 28.584049079754603, 6m 8.448547065154397, 12m 85.71631105125117, composite 40.4389979871986 (Strong Uptrend)
Lynch category: Speculative (confidence: Low)
Screener: long score 4, short score 9, recommendation: Short
Revenue growth 1y (%): 38.820716178785645
Revenue deceleration: no
Accrual ratio: -0.041145145710670926
FCF conversion rate: -0.2119378077587524
Beneish M-score: -2.445243322469336 (Likely Safe)
ROE (%): -4.8812668313240675
Net margin (%): -12.214416545610096
Asset turnover: 0.2779492740699601
Equity multiplier (leverage): 1.4377860912778713
ROE archetype: Low Return
FCF z-score: 3.070396362132488
Treasury beta 1y: -0.0008334805747005138 (R-squared: 6.875279790561046e-05)
Insider 90-day net shares: -362371 (net value USD: -81377833.00)
ROIC (%): -28.781483571386584 (pretax: -36.43225768529948)
Incremental ROIC 3y (%): 30.58086283389635 (pretax: 38.70995295429918)
Capital allocation category: Turnaround Compounder
Industry percentiles: P/E , P/B 67.64705882352942, ROIC 61.029411764705884, revenue growth 1y 6.61764705882353, 6m momentum 21.323529411764707
Sector percentiles: P/E , 6m momentum 20.988538681948423
Industry median P/E: 21.640734060420083; industry median ROIC: 2.9089897435686405
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.1292037521814271
Base cash flow: -270864000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for NTSK (Technology — Software - Infrastructure, United States)
Report date: 2026-04-30 (quarterly)
Stock price: 11.53
Market cap: 4657239552 (USD: 4657239552)
P/B ratio: 14.29011488023884
Debt to equity: 4.2538
Current ratio: 2.17
Return on net tangible assets (%): -116.53681883544738
Buffett classification: The Gruesome
Analyst consensus upside (%): 61.746987951807206
Rule of 40 score: -64.53181121202947
Altman Z-score: 0.002415284059139128 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.18354220143838545
Total shareholder yield (%): 0.18354220143838545 (Low Return)
Momentum (%): 1m 21.36842105263157, 3m 19.730010384215976, 6m -24.59123610202747, 12m , composite -2.4306128589057465 (Strong Downtrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 0, short score 16, recommendation: Strong Short (Melting Ice Cube)
Revenue growth 1y (%): 27.803418369934583
Revenue deceleration: no
Revenue growth consistency score: 3.123857143303118
Accrual ratio: -0.032933916476746594
FCF conversion rate: 0.5104552946023898
Beneish M-score: -2.742420804608093 (Likely Safe)
ROE (%): -62.96281283188352
Net margin (%): -57.78800746061352
Asset turnover: 0.11641616851447131
Equity multiplier (leverage): 9.359078711623118
ROE archetype: Low Return
FCF z-score: 1.4434323896114594
Treasury beta 1y: 0.012993264956146833 (R-squared: 0.006617981962908737)
Insider 90-day net shares: -1696316 (net value USD: -11039281.00)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 64.70588235294117, ROIC , revenue growth 1y 17.873303167420815, 6m momentum 52.71493212669684
Sector percentiles: P/E , 6m momentum 59.29262595929262
Industry median P/E: 5.36821412369575; industry median ROIC: 3.7232145830700096
Sector median P/E: 1.5433673469387754; sector median ROIC: 6.677876317240262
WACC: 0.09365930310968512
Base cash flow: -656406000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for NTX.V (Basic Materials — Other Industrial Metals & Mining, Canada)
Report date: 2026-03-31 (quarterly)
Stock price: 0.07801418439716312
Market cap: 9113672 (USD: 6556598.56115108)
P/B ratio: 3.7151892236888715
Debt to equity: 0
Current ratio: 48.04
Return on net tangible assets (%): -9.247290451897767
Buffett classification: The Gruesome
Rule of 40 score: 0
Altman Z-score: 93.01748678328595 (Safe Zone)
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m 23.08904649330182, 3m -2.8368794326241105, 6m -51.06382978723405, 12m -60.70396637772524, composite -40.65860886358339 (Strong Downtrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 4, short score 9, recommendation: Short
Revenue deceleration: no
Accrual ratio: 0.1598499655921612
FCF conversion rate: 3.040163093111781
Beneish M-score: -1.3473030127557901 (Strong Manipulation Signal)
ROE (%): -8.771766773161046
Asset turnover: 0
Equity multiplier (leverage): 1.119539486023197
ROE archetype: Low Return
Treasury beta 1y: 0.0028901795238230827 (R-squared: 0.00011728546339440844)
Insider 90-day net shares: 25500 (net value USD: 1742.00)
ROIC (%): -559.2351327227393 (pretax: -707.8925730667587)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 39.217318900915906, ROIC 57.285595337218986, revenue growth 1y , 6m momentum 65.02914238134888
Sector percentiles: P/E , 6m momentum 72.68184342032204
Industry median P/E: 6.295008083084309; industry median ROIC: -14.271466134226909
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.05
Base cash flow: -1109257.6642335765
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for NU (Financial Services — Banks - Regional, Brazil)
Report date: 2026-03-31 (quarterly)
Stock price: 14.09
Market cap: 68061528064 (USD: 68061528064)
P/E ratio: 22.107692307692307
P/B ratio: 22.857961341410405
Debt to equity: 0.15228625300254311
Return on net tangible assets (%): 7.856853265389074
Buffett classification: The Gruesome
Analyst consensus upside (%): 25.121781489213653
Rule of 40 score: -21.26932374193589
Piotroski F-score: 4 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -0.02679553065191996
Total shareholder yield (%): -0.02679553065191996 (Minimal or Negative)
Momentum (%): 1m 13.081861958266444, 3m -2.8945554789800134, 6m -21.895787139689578, 12m 10.509803921568626, composite -9.02161747419705 (Moderate Downtrend)
Lynch category: Fast Grower (confidence: Medium)
Screener: long score 2, short score 3, recommendation: Neutral
Revenue growth 1y (%): 72.1779495849961
Net income growth 1y (%): 71.38143333086038
Revenue deceleration: no
Accrual ratio: 0.028943149422090465
FCF conversion rate: -1.4783236397662536
Beneish M-score: -2.3152014846619777 (Likely Safe)
ROE (%): 7.434764745674732
Net margin (%): 24.64611636628786
Asset turnover: 0.04738482407606241
Equity multiplier (leverage): 6.366188059424944
ROE archetype: Standard Business
P/E z-score: 4.0615949144756875
FCF z-score: 4.828807354811142
Treasury beta 1y: -0.001960456226220977 (R-squared: 0.0005407924818742197)
Insider 90-day net shares: -21000 (net value USD: -257042.00)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 85.40372670807453, P/B 66.14906832298136, ROIC , revenue growth 1y 1.0869565217391304, 6m momentum 91.77018633540372
Sector percentiles: P/E 48.21520951888257, 6m momentum 60.73460941541645
Industry median P/E: 10.091388400702987; industry median ROIC: 0.8427644093631484
Sector median P/E: 9.286368843069873; sector median ROIC: 1.3915857507207385
WACC: 0.10082562450228533
Base cash flow: 540588503.6496351
DCF price per share: base 1.0722550717926602, conservative 0.701741895624302, aggressive 1.7272503041187182
Financial scorecard for NUVL (Healthcare — Biotechnology, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 123.96
Market cap: 9808736256 (USD: 9808736256)
P/B ratio: 6.4288646719040985
Debt to equity: 0
Current ratio: 16.14
Return on net tangible assets (%): -9.305353437213409
Buffett classification: The Gruesome
Analyst consensus upside (%): 21.034651049292336
Rule of 40 score: 0
Altman Z-score: 37.21031278952859 (Safe Zone)
Piotroski F-score: 4 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m 0.4375303840544418, 3m 15.709885186222348, 6m 17.020674030019812, 12m 50.32743148193064, composite 27.467709244770514 (Strong Uptrend)
Lynch category: Speculative (confidence: Low)
Screener: long score 4, short score 8, recommendation: Short
Revenue deceleration: no
Accrual ratio: -0.012303866132770232
FCF conversion rate: 0.8455329935303215
Beneish M-score: -2.4922108283859714 (Likely Safe)
ROE (%): -9.021234933169769
Asset turnover: 0
Equity multiplier (leverage): 1.1325571489070485
ROE archetype: Low Return
Treasury beta 1y: -0.004793466607705835 (R-squared: 0.0013219884206961382)
Insider 90-day net shares: -196901 (net value USD: -21609192.00)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 51.985559566786996, ROIC , revenue growth 1y , 6m momentum 16.877256317689532
Sector percentiles: P/E , 6m momentum 15.830945558739254
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.1096
Base cash flow: -425377000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for OGD.TO (Basic Materials — Other Industrial Metals & Mining, Canada)
Report date: 2026-03-31 (quarterly)
Stock price: 0.8723404255319149
Market cap: 46950256 (USD: 33777162.58992806)
P/E ratio: 18.499486125385406
P/B ratio: 0.983406904547211
Debt to equity: 0.5884
Current ratio: 2.24
Interest coverage ratio: -2.3565217391304345
Return on net tangible assets (%): -2.541969882556381
Buffett classification: The Gruesome
Rule of 40 score: -6.480387057133822
Altman Z-score: 1.189609327059707 (Distress Zone)
Piotroski F-score: 1 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0.0809367258828152
Debt paydown yield (%): -12.683947847699626
Total shareholder yield (%): -12.603011121816811 (Minimal or Negative)
Momentum (%): 1m 1.5347052668294339, 3m -32.4798653684337, 6m -27.914383997961522, 12m -27.6595744680851, composite -29.71575173543759 (Strong Downtrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 1, short score 11, recommendation: Strong Short (Melting Ice Cube)
Revenue growth 1y (%): 5.606636454977898
Net income growth 1y (%): -165.998052280487
Revenue deceleration: no
Revenue growth consistency score: 6.885522735537305
Accrual ratio: 0.03413711776239
FCF conversion rate: 5.092577147623018
Beneish M-score: -1.508996805699868 (Possible Manipulation)
ROE (%): -1.6910536597578998
Net margin (%): -2.3330479452054798
Asset turnover: 0.3575249146208981
Equity multiplier (leverage): 2.027343846513689
ROE archetype: Low Return
Treasury beta 1y: -0.00338791125530626 (R-squared: 0.000541203218610131)
Insider 90-day net shares: -67600 (net value USD: -86527.00)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 12.656119900083265, P/B 14.571190674437966, ROIC , revenue growth 1y 6.1615320566194836, 6m momentum 40.96586178184846
Sector percentiles: P/E 29.955580233203776, 6m momentum 52.748473070516376
Industry median P/E: 6.295008083084309; industry median ROIC: -14.271466134226909
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.10905000000000001
Base cash flow: 0
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for OOR.V (Basic Materials — Gold, Canada)
Report date: 2026-02-28 (quarterly)
Stock price: 0.0425531914893617
Market cap: 14951795 (USD: 10913718.978102189)
P/B ratio: 4.285629637868761
Debt to equity: 0
Current ratio: 1.73
Return on net tangible assets (%): -0.8609594008036462
Buffett classification: The Gruesome
Rule of 40 score: 0
Altman Z-score: 2.4466228875298555 (Grey Zone)
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m 0.7092198581560277, 3m -27.127659574468083, 6m -26.595744680851073, 12m -17.325227963525844, composite -23.876949641109068 (Strong Downtrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 3, short score 10, recommendation: Strong Short (Melting Ice Cube)
Revenue deceleration: no
Accrual ratio: 0.047580808573551375
FCF conversion rate: 6.423929850260416
Beneish M-score: -2.7529628217541164 (Likely Safe)
ROE (%): -1.0826968416132612
Asset turnover: 0
Equity multiplier (leverage): 1.2342101561664418
ROE archetype: Low Return
Treasury beta 1y: 0.00028442409599241803 (R-squared: 9.008997150863057e-07)
Insider 90-day net shares: 350000 (net value USD: 16700.00)
ROIC (%): -30.69783161400797 (pretax: -38.85801470127591)
Incremental ROIC 3y (%): -64.41147375211682 (pretax: -81.53351107862889)
Capital allocation category: Value Destroyer
Industry percentiles: P/E , P/B 42.06798866855524, ROIC 42.91784702549575, revenue growth 1y , 6m momentum 37.53541076487252
Sector percentiles: P/E , 6m momentum 51.24930594114381
Industry median P/E: 8.322060300477567; industry median ROIC: -7.9824265928961236
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.12775
Base cash flow: -899116.0583941605
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for OVID (Healthcare — Biotechnology, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 2.36
Market cap: 434871424 (USD: 434871424)
P/B ratio: 2.08979228442167
Debt to equity: 0.0659
Current ratio: 10.17
Return on net tangible assets (%): -8.550504617464153
Buffett classification: The Gruesome
Analyst consensus upside (%): 146.39639639639637
Rule of 40 score: -100
Altman Z-score: 7.942356555176811 (Safe Zone)
Piotroski F-score: 4 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.08025360617854715
Total shareholder yield (%): 0.08025360617854715 (Low Return)
Momentum (%): 1m -5.600000000000005, 3m -9.230769230769239, 6m 39.64497041420118, 12m 242.02898550724638, composite 97.57768058771403 (Strong Uptrend)
Lynch category: Speculative (confidence: Low)
Screener: long score 4, short score 8, recommendation: Short
Revenue growth 1y (%): -100
Revenue deceleration: no
Accrual ratio: -0.016406328838278954
FCF conversion rate: 0.8181657640687544
Beneish M-score: -3.6613182614266933 (Likely Safe)
ROE (%): -10.329280787039147
Asset turnover: 0
Equity multiplier (leverage): 1.144812406324769
ROE archetype: Low Return
Treasury beta 1y: -0.0011296307023314976 (R-squared: 2.1089773943086194e-05)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): -45.036282306163024 (pretax: -57.007952286282304)
Incremental ROIC 3y (%): 18.95382420570199 (pretax: 23.992182538863283)
Capital allocation category: Turnaround Compounder
Industry percentiles: P/E , P/B 24.729241877256317, ROIC 19.133574007220215, revenue growth 1y 29.693140794223826, 6m momentum 10.379061371841155
Sector percentiles: P/E , 6m momentum 8.130372492836676
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.0571599369372202
Base cash flow: -17141000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for PAYO (Technology — Software - Infrastructure, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 7.12
Market cap: 2407944192 (USD: 2407944192)
P/E ratio: 24.15
P/B ratio: 2.478441675332853
Debt to equity: 0.12140000000000001
Current ratio: 1
Interest coverage ratio: -26.497536945812808
Return on net tangible assets (%): 7.905279485777415
Buffett classification: The Gruesome
Analyst consensus upside (%): 53.209109730848866
Rule of 40 score: -1.8849930349922341
Altman Z-score: 0.22515770425404918 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Dividend yield (%): 0
Buyback yield (%): 3.1143163636908744
Debt paydown yield (%): -0.319442619374461
Total shareholder yield (%): 2.7948737443164133 (Low Return)
Momentum (%): 1m 0.423131170662909, 3m 39.33463796477494, 6m 15.584415584415584, 12m 5.952380952380958, composite 20.141668643380967 (Flat)
Lynch category: Slow Grower (confidence: Medium)
Screener: long score 4, short score 8, recommendation: Neutral
Revenue growth 1y (%): 11.35095019746084
Net income growth 1y (%): -4.903533070904409
Revenue deceleration: no
Accrual ratio: -0.0003983002740877816
FCF conversion rate: 1.178659035159444
Beneish M-score: -2.623349782266517 (Likely Safe)
ROE (%): 2.8702561492392387
Net margin (%): 9.315522379533272
Asset turnover: 0.02393196767000321
Equity multiplier (leverage): 12.874638247688672
ROE archetype: Low Return
P/E z-score: 4.088505049482467
FCF z-score: 4.860272680669088
Treasury beta 1y: 0.001589260267936795 (R-squared: 0.00018271089234425894)
Insider 90-day net shares: -25000 (net value USD: -175250.00)
ROIC (%): -19.244497166570234 (pretax: -29.60691871780036)
Incremental ROIC 3y (%): -5.829829948759192 (pretax: -8.96896915193722)
Capital allocation category: Value Destroyer
Industry percentiles: P/E 38.68778280542987, P/B 34.38914027149321, ROIC 56.334841628959275, revenue growth 1y 35.06787330316742, 6m momentum 14.93212669683258
Sector percentiles: P/E 41.9753086419753, 6m momentum 20.92092092092092
Industry median P/E: 5.36821412369575; industry median ROIC: 3.7232145830700096
Sector median P/E: 1.5433673469387754; sector median ROIC: 6.677876317240262
WACC: 0.09850606879240177
Base cash flow: 111943000
DCF price per share: base 10.861801489813264, conservative 6.926384086184367, aggressive 17.586313874766795
Financial scorecard for PBEE.L (Financial Services — Capital Markets, United Kingdom)
Report date: 2025-12-31 (annual)
Stock price: 0.016666666666666666
Market cap: 298575744 (USD: 403480735.1351351)
P/B ratio: 0.1073322318539887
Debt to equity: 0.0034999999999999996
Current ratio: 9.34
Interest coverage ratio: -222.94117647058823
Return on net tangible assets (%): -7.530731927371153
Buffett classification: The Gruesome
Analyst consensus upside (%): 939562.9629629628
Rule of 40 score: 23.585683568297128
Altman Z-score: 42.454929244192286 (Safe Zone)
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.030450500432874433
Total shareholder yield (%): 0.030450500432874433 (Low Return)
Momentum (%): 1m 1.3333333333333375, 3m -14.942528735632173, 6m -24.335378323108376, 12m -28.709055876685934, composite -22.97500055796372 (Strong Downtrend)
Lynch category: Speculative (confidence: Low)
Screener: long score 2, short score 2, recommendation: Neutral
Revenue growth 1y (%): 38.73705648545271
Revenue CAGR 3y (%): 39.349690607950464
Revenue deceleration: no
Revenue growth consistency score: 2.0764968543897906
Accrual ratio: -0.01848768210366872
FCF conversion rate: 0.7456140350877193
Beneish M-score: -2.25493694928497 (Likely Safe)
Equity multiplier (leverage): 1.172834245697883
ROE archetype: Standard Business
Treasury beta 1y: 0.0050011663109104845 (R-squared: 0.003927564826579818)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): -84.24592009003929 (pretax: -106.64040517726492)
Incremental ROIC 3y (%): 1125.2071660374831 (pretax: 1424.3128684018775)
Capital allocation category: Turnaround Compounder
Industry percentiles: P/E , P/B 6.043956043956044, ROIC 57.96703296703297, revenue growth 1y 15.659340659340659, 6m momentum 60.98901098901099
Sector percentiles: P/E , 6m momentum 61.79513709260217
Industry median P/E: 0.9254498714652956; industry median ROIC: 1.51204420306575
Sector median P/E: 9.286368843069873; sector median ROIC: 1.3915857507207385
WACC: 0.07057085867863892
Base cash flow: -3609459.4594594594
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for PEN (Healthcare — Medical Devices, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 318.73
Market cap: 12536104960 (USD: 12536104960)
P/E ratio: 75.83602771362587
P/B ratio: 8.763166555334058
Debt to equity: 0.1467
Current ratio: 6.02
Interest coverage ratio: 120.61198738170347
Return on net tangible assets (%): 1.804919321558746
Buffett classification: The Good
Analyst consensus upside (%): 10.113591375582416
Rule of 40 score: 12.893931487208963
Altman Z-score: 18.84914424826605 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Magic formula: return on capital % 2.7442980844319904, earnings yield % 0.31503004872188783, rank 2294
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.028110804841251107
Total shareholder yield (%): 0.028110804841251107 (Low Return)
Momentum (%): 1m 0.7491465419142763, 3m -3.3829458304283153, 6m -11.281523130880135, 12m 38.46989312711791, composite 7.591931726599502 (Strong Uptrend)
Lynch category: Slow Grower (confidence: Medium)
Screener: long score 6, short score 3, recommendation: Neutral
Revenue growth 1y (%): 15.616091812179933
Net income growth 1y (%): -16.926293246309566
Revenue deceleration: no
Accrual ratio: -0.021861191954699075
FCF conversion rate: 2.24957034127179
Beneish M-score: -2.6666866155710753 (Likely Safe)
ROE (%): 2.246076483371045
Net margin (%): 8.694677631965162
Asset turnover: 0.20121467173983484
Equity multiplier (leverage): 1.283841504920875
ROE archetype: Low Return
P/E z-score: 3.781584545640292
FCF z-score: 3.7815845456402912
Treasury beta 1y: -0.0011038771909652224 (R-squared: 0.0002154180107033225)
Insider 90-day net shares: -2532 (net value USD: -865296.00)
ROIC (%): 14.86954128310205 (pretax: 17.165660153507616)
Incremental ROIC 3y (%): 286.2687857393227 (pretax: 327.7570009841639)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 29.970326409495552, P/B 56.37982195845698, ROIC 7.71513353115727, revenue growth 1y 23.14540059347181, 6m momentum 36.20178041543027
Sector percentiles: P/E 32.55730659025788, 6m momentum 41.189111747851
Industry median P/E: 21.626420273203117; industry median ROIC: -5.9391058628332924
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.0839840032113162
Base cash flow: 131429000
DCF price per share: base 160.07090420587474, conservative 92.35770697456982, aggressive 283.95643391717425
Financial scorecard for PHA.V (Healthcare — Medical Care Facilities, Canada)
Report date: 2025-12-31 (quarterly)
Stock price: 0
Market cap: 277570 (USD: 202605.83941605838)
Debt to equity: -3.2180592796579477
Current ratio: 0.34
Interest coverage ratio: -1.2607287449392715
Buffett classification: The Gruesome
Rule of 40 score: -14.710576704585062
Altman Z-score: -1.604622872525355 (Distress Zone)
Piotroski F-score: 4 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -243.3270446005824
Total shareholder yield (%): -243.3270446005824 (Minimal or Negative)
Momentum (%): 1m , 3m -100, 6m -100, 12m -100, composite -100 (Strong Downtrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 1, short score 10, recommendation: Strong Short (Melting Ice Cube)
Revenue growth 1y (%): -42.06369074283908
Revenue deceleration: no
Accrual ratio: -0.050935505396555385
FCF conversion rate: 0.1090623774029031
Beneish M-score: -2.522117839097141 (Likely Safe)
Net margin (%): -14.292122231567141
Asset turnover: 0.4000152966744013
ROE archetype: Standard Business
FCF z-score: -0.14310865676494955
Treasury beta 1y: 0.0008177881944400335 (R-squared: 1.0295207148767172e-06)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): -21.42719242902208 (pretax: -27.123028391167193)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B , ROIC 72.85714285714285, revenue growth 1y 60, 6m momentum 83.80952380952381
Sector percentiles: P/E , 6m momentum 80.90974212034384
Industry median P/E: 1.7425206697700268; industry median ROIC: 5.681103510179656
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.09611286269641095
Base cash flow: -5253956.8345323745
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for PLMK (Financial Services — Shell Companies, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 10.61
Market cap: 257216912 (USD: 257216912)
P/E ratio: 42.24
P/B ratio: 1.1126247204077213
Debt to equity: 0.0014243619425393476
Current ratio: 0.43
Return on net tangible assets (%): 0.6832003334419913
Buffett classification: The Gruesome
Rule of 40 score: 0
Altman Z-score: 20.64480943405931 (Safe Zone)
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m -0.2819548872180558, 3m 0.18885741265344264, 6m 1.0476190476190421, 12m 3.0097087378640652, composite 1.512482444686297 (Flat)
Lynch category: Slow Grower (confidence: Low)
Screener: long score 4, short score 9, recommendation: Short
Net income growth 1y (%): 1.444856626806712
Revenue deceleration: no
Accrual ratio: 0.0076888087219341705
FCF conversion rate: -0.16906951183103808
Beneish M-score: -2.48255356358952 (Likely Safe)
ROE (%): 0.6855421465575746
Asset turnover: 0
Equity multiplier (leverage): 1.0423544811686465
ROE archetype: Low Return
P/E z-score: 1.51800184336428
Treasury beta 1y: 0.00028674188977566637 (R-squared: 0.00020893975240380045)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): -0.46295597228657814 (pretax: -0.5860202180842761)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 11.200000000000001, P/B 21.6, ROIC 7.199999999999999, revenue growth 1y , 6m momentum 17.333333333333336
Sector percentiles: P/E 54.449042938437664, 6m momentum 38.075530263838594
Industry median P/E: 51.21654844258756; industry median ROIC: -0.6045051234646484
Sector median P/E: 9.286368843069873; sector median ROIC: 1.3915857507207385
WACC: 0.10182460069507794
Base cash flow: 6051821
DCF price per share: base 6.513392400642729, conservative 4.707274575748547, aggressive 9.11425842315108
Financial scorecard for PLMR (Financial Services — Insurance - Property & Casualty, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 137.56
Market cap: 3645872640 (USD: 3645872640)
P/E ratio: 15.641361256544503
P/B ratio: 3.302485701311417
Debt to equity: 0.31010000000000004
Current ratio: 0.54
Return on net tangible assets (%): 5.990879084036714
Buffett classification: The Gruesome
Analyst consensus upside (%): 37.238493723849366
Rule of 40 score: 25.261169673205636
Piotroski F-score: 4 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0.633264029760513
Total shareholder yield (%): 0.633264029760513 (Low Return)
Momentum (%): 1m 15.684130855268696, 3m 9.113984294439605, 6m 10.092036814725889, 12m 4.3940198831296895, composite 3.1488639335072115 (Moderate Downtrend)
Lynch category: Slow Grower (confidence: Medium)
Screener: long score 4, short score 1, recommendation: Neutral
Revenue growth 1y (%): 59.72811553371928
Net income growth 1y (%): 0.05824518894739228
Revenue deceleration: no
Accrual ratio: -0.0006255160732718243
FCF conversion rate: 1.0485249260716698
Beneish M-score: -2.3639746258729435 (Likely Safe)
ROE (%): 4.516681337704146
Net margin (%): 15.39661143336512
Asset turnover: 0.08372370558843384
Equity multiplier (leverage): 3.5038528563300533
ROE archetype: Low Return
P/E z-score: 5.037404478453455
FCF z-score: 5.037404478453454
Treasury beta 1y: 0.0011645645089313184 (R-squared: 0.0001764645193676478)
Insider 90-day net shares: -83170 (net value USD: -10891654.00)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 84.72222222222221, P/B 75, ROIC , revenue growth 1y 1.3888888888888888, 6m momentum 58.333333333333336
Sector percentiles: P/E 43.843766166580444, 6m momentum 22.090015519917227
Industry median P/E: 8.869425040300914; industry median ROIC: 35.8357333390367
Sector median P/E: 9.286368843069873; sector median ROIC: 1.3915857507207385
WACC: 0.06945000000000001
Base cash flow: 205788000
DCF price per share: base 515.7714555328012, conservative 286.02063153354027, aggressive 955.9351144621659
Financial scorecard for PLSR.V (Basic Materials — Other Industrial Metals & Mining, Portugal)
Report date: 2026-03-31 (quarterly)
Stock price: 1.0212765957446808
Market cap: 308256128 (USD: 354317388.50574714)
P/B ratio: 23.786909243608033
Debt to equity: 0.004
Current ratio: 10.48
Interest coverage ratio: -7111.045454545454
Return on net tangible assets (%): -54.545956446340604
Buffett classification: The Gruesome
Rule of 40 score: 0
Altman Z-score: 151.33231630222684 (Safe Zone)
Piotroski F-score: 4 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m 0.7092198581560223, 3m -12.553191489361701, 6m -21.26470937834306, 12m 177.78723404255317, composite 47.3376950159294 (Strong Uptrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 4, short score 8, recommendation: Short
Revenue deceleration: no
Accrual ratio: -0.02084710072842077
FCF conversion rate: 0.9690476311101637
Beneish M-score: -2.5738253736038836 (Likely Safe)
ROE (%): -81.9697234664017
Asset turnover: 0
Equity multiplier (leverage): 1.2170311601512251
ROE archetype: Low Return
Treasury beta 1y: 0.015755055511273503 (R-squared: 0.0027619409363039056)
Insider 90-day net shares: -10950888 (net value USD: -13979452.00)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 57.368859283930064, ROIC , revenue growth 1y , 6m momentum 34.63780183180683
Sector percentiles: P/E , 6m momentum 45.474736257634646
Industry median P/E: 6.295008083084309; industry median ROIC: -14.271466134226909
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.05
Base cash flow: -11942312.941176472
DCF price per share: base 0, conservative 0, aggressive 0